Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities

Open access

Abstract

Nicotinamide riboside (NR) is one of the orally bioavailable NAD+ precursors and has been demonstrated to exhibit beneficial effects against aging and aging-associated diseases. However, the metabolic pathway of NR in vivo is not yet fully understood. Here, we demonstrate that orally administered NR increases NAD+ level via two different pathways. In the early phase, NR was directly absorbed and contributed to NAD+ generation through the NR salvage pathway, while in the late phase, NR was hydrolyzed to nicotinamide (NAM) by bone marrow stromal cell antigen 1 (BST1), and was further metabolized by the gut microbiota to nicotinic acid, contributing to generate NAD+ through the Preiss–Handler pathway. Furthermore, we report BST1 has a base-exchange activity against both NR and nicotinic acid riboside (NAR) to generate NAR and NR, respectively, connecting amidated and deamidated pathways. Thus, we conclude that BST1 plays a dual role as glycohydrolase and base-exchange enzyme during oral NR supplementation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-021-27080-3

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Time-course analysis of NAD+ metabolome after the gavage of NR. 400 mg/kg NR was administered to wild-type mice (n = 6 mice per time point) by gavage and killed after 0 m, 15 m, 30 m, 1 h, and 3 h for tissue collection. Relative abundance of NAD+ metabolome in the liver (a) and small intestine (b) were shown. Data are shown as mean ± S.D. *P < 0.05, **P < 0.01 as determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.
Fig. 1 Time-course analysis of NAD+ metabolome after the gavage of NR. 400 mg/kg NR was administered to wild-type mice (n = 6 mice per time point) by gavage and killed after 0 m, 15 m, 30 m, 1 h, and 3 h for tissue collection. Relative abundance of NAD+ metabolome in the liver (a) and small intestine (b) were shown. Data are shown as mean ± S.D. *P < 0.05, **P < 0.01 as determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 2 Gut microbiota is important for NAD+ increase in the late phase after NR administration. Wild-type mice were treated with either regular water (Ctrl) or antibiotic-containing water (Abx) for 3 days to deplete gut microbiota. They were then gavaged with 400 mg/kg NR or equivalent molar amount of NAR, and killed after 30 min or 3 h. a, b Concentrations of NAD+ metabolome in the liver were measured by LC-MS 3 h after the gavage of NR (a) (n = 6 mice per group) and NAR (b) (n = 6 mice per group). c, d Concentrations of NAD metabolome in the liver (c) (n = 6 mice per group) and small intestine (d) (n = 6 mice per group) were measured by LC/MS 30 min after the gavage of NR. Data are shown as mean ± S.D. ns not significant. Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.
Fig. 2 Gut microbiota is important for NAD+ increase in the late phase after NR administration. Wild-type mice were treated with either regular water (Ctrl) or antibiotic-containing water (Abx) for 3 days to deplete gut microbiota. They were then gavaged with 400 mg/kg NR or equivalent molar amount of NAR, and killed after 30 min or 3 h. a, b Concentrations of NAD+ metabolome in the liver were measured by LC-MS 3 h after the gavage of NR (a) (n = 6 mice per group) and NAR (b) (n = 6 mice per group). c, d Concentrations of NAD metabolome in the liver (c) (n = 6 mice per group) and small intestine (d) (n = 6 mice per group) were measured by LC/MS 30 min after the gavage of NR. Data are shown as mean ± S.D. ns not significant. Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 3 NR and NAM increased NAD+ levels in the liver of Naprt KO mice in the early phase but not in the late phase. Wild-type (WT) mice and Naprt KO mice were gavaged with 400 mg/kg NR or equivalent molar amount of NAM, then killed after 30 min or 3 h of the gavage. a, b Concentrations of NAD+ metabolome in the liver were measured by LC/MS 3 h after the gavage of NR (a) (n = 3 mice per group) or NAM (b) (n = 4 mice per group). c, d Concentrations of NAD+ metabolome in the liver were measured by LC/MS 30 min after the gavage of NR (c) (n = 5 mice per group) or NAM (d) (n = 4 mice per group). Data are shown as mean ± S.D. ns not significant. Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.
Fig. 3 NR and NAM increased NAD+ levels in the liver of Naprt KO mice in the early phase but not in the late phase. Wild-type (WT) mice and Naprt KO mice were gavaged with 400 mg/kg NR or equivalent molar amount of NAM, then killed after 30 min or 3 h of the gavage. a, b Concentrations of NAD+ metabolome in the liver were measured by LC/MS 3 h after the gavage of NR (a) (n = 3 mice per group) or NAM (b) (n = 4 mice per group). c, d Concentrations of NAD+ metabolome in the liver were measured by LC/MS 30 min after the gavage of NR (c) (n = 5 mice per group) or NAM (d) (n = 4 mice per group). Data are shown as mean ± S.D. ns not significant. Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 4 BST1 is required for the conversion of NR into NAM in vitro and in vivo. a–d Enzymatic activities of BST1 and CD38 as a glycohydrolase and cyclase were determined. a NR hydrolase activities were measured by the degradation rate of NR. (n = 3 independent experiments). b NAD+ hydrolase activities were measured by the production rate of ADP-ribose (ADPR). (n = 3 independent experiments). c NMN hydrolase activities were measured by the degradation rate of NMN. (n = 3 independent experiments). d ADP-ribosyl cyclase activities were measured by the production rate of cyclic ADP-ribose (cADPR). (n = 3 independent experiments). Data are shown as mean ± S.D. e, f mRNA expression of Bst1 (e, n = 3 independent experiments) and Cd38 (f, n = 3 independent experiments) in various tissues of wild type mice were measured by quantitative PCR (BAT brown adipose tissue, WAT white adipose tissue, SI small intestine, LI large intestine). Data are shown as mean ± S.D. g–i WT and BST1 KO mice were gavaged with 400 mg/kg NR, or equivalent molar amount of NAR or NAM, and then were killed after 3 h of the gavage. Concentrations of NAD+ metabolome in the liver were measured by LC/MS 3 h after the gavage of NR (g, n = 6 mice per group), NAR (h, n = 6 mice per group), and NAM (i, n = 6 mice per group). Data are shown as mean ± S.D. ns not significant. Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.
Fig. 4 BST1 is required for the conversion of NR into NAM in vitro and in vivo. a–d Enzymatic activities of BST1 and CD38 as a glycohydrolase and cyclase were determined. a NR hydrolase activities were measured by the degradation rate of NR. (n = 3 independent experiments). b NAD+ hydrolase activities were measured by the production rate of ADP-ribose (ADPR). (n = 3 independent experiments). c NMN hydrolase activities were measured by the degradation rate of NMN. (n = 3 independent experiments). d ADP-ribosyl cyclase activities were measured by the production rate of cyclic ADP-ribose (cADPR). (n = 3 independent experiments). Data are shown as mean ± S.D. e, f mRNA expression of Bst1 (e, n = 3 independent experiments) and Cd38 (f, n = 3 independent experiments) in various tissues of wild type mice were measured by quantitative PCR (BAT brown adipose tissue, WAT white adipose tissue, SI small intestine, LI large intestine). Data are shown as mean ± S.D. g–i WT and BST1 KO mice were gavaged with 400 mg/kg NR, or equivalent molar amount of NAR or NAM, and then were killed after 3 h of the gavage. Concentrations of NAD+ metabolome in the liver were measured by LC/MS 3 h after the gavage of NR (g, n = 6 mice per group), NAR (h, n = 6 mice per group), and NAM (i, n = 6 mice per group). Data are shown as mean ± S.D. ns not significant. Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 5 Oral administration of NR and NA increases NAD+ levels in the small intestine of NADS KO mice even in the late phase. Wild-type (WT) mice and NADS KO mice were gavaged with 400 mg/kg NR or equivalent molar amount of NA, and then were killed after 3 h of the gavage. a, b Concentrations of NAD+ metabolome in the liver (a, n = 5 mice per WT mice group, n = 6 mice per NADS KO mice group) and small intestine (b, n = 5 mice per WT mice group, n = 6 mice per NADS KO mice group were measured by LC/MS 3 h after the gavage of NR. c Concentrations of NAD+ metabolome in the small intestine was measured by LC/MS 3 h after the gavage of NA (n = 5 mice per saline-treated WT mice group, n = 4 mice per NA-treated WT mice group, and n = 4 mice per NA or saline-treated NADS KO mice group). Results were shown as mean ± S.D. Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.
Fig. 5 Oral administration of NR and NA increases NAD+ levels in the small intestine of NADS KO mice even in the late phase. Wild-type (WT) mice and NADS KO mice were gavaged with 400 mg/kg NR or equivalent molar amount of NA, and then were killed after 3 h of the gavage. a, b Concentrations of NAD+ metabolome in the liver (a, n = 5 mice per WT mice group, n = 6 mice per NADS KO mice group) and small intestine (b, n = 5 mice per WT mice group, n = 6 mice per NADS KO mice group were measured by LC/MS 3 h after the gavage of NR. c Concentrations of NAD+ metabolome in the small intestine was measured by LC/MS 3 h after the gavage of NA (n = 5 mice per saline-treated WT mice group, n = 4 mice per NA-treated WT mice group, and n = 4 mice per NA or saline-treated NADS KO mice group). Results were shown as mean ± S.D. Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 6 BST1 exhibited a base-exchange activity against NR and NAR. a Scheme showing a base-exchange reaction between non-labeled NR and d4-NA to generate d4-NAR and non-labeled NAM. b, c NR and d4-NA were incubated with mouse intestinal tissue lysate or buffer for 30 min at room temperature. Then, the whole mixture was subjected to LC/MS analysis to detect d4-NAR as a product of base-exchange reaction. Representative MRM chromatograms (b) and calculated MS counts (cof d4-NAR after the incubation with lysates were shown (n = 3 independent experiments). d Only NR was incubated with mouse intestinal tissue lysate for 30 min at room temperature. Then, the whole mixture was subjected to LC/MS analysis to detect non-labeled NAR as a product of direct deamidation. Representative MRM chromatograms of non-labeled after the incubation with lysates were shown. e Caco2 cells were cultured with non-labeled NR and d4-NA for 4 h. Then, metabolites were extracted from cells and subjected to LC/MS analysis for the detection of d4-NAR (n = 3 independent experiments). f NR and d4-NA were incubated with intestinal tissue lysates from WT, CD38 KO, or BST1 KO mice for 30 min at room temperature. Then, the mixture was subjected to LC/MS analysis for d4-NAR detection (n = 4 independent experiments). g Non-labeled NR and d4-NA were incubated with recombinant CD38 or BST1 protein for 30 min at room temperature. Then, the mixture was subjected to LC/MS analysis for the detection of d4-NAR (n = 3 independent experiments). h Non-labeled NAR and d4-NAM were incubated with recombinant CD38 or BST1 protein for 30 min at room temperature. Then, the mixture was subjected to LC/MS analysis for the detection of d4-NR (n = 3 independent experiments). i Enzyme activity of BST1 for NR and NAR to catalyze base-exchange reaction. Recombinant BST1 protein was incubated with various concentrations of NR and 1 mM NA or NAR and 1 mM NAM and the produced NAR or NR, respectively, was measured by LC/MS analysis. Michaelis–Menten curve fit was produced with GraphPad Prism software. Right panel shows Km and Vmax. (n = 3 independent experiments) c, e–h Data are shown as mean ± S.D. i Each data point is shown. b, d Three independent experiments were performed. Source data are provided as a Source Data file.
Fig. 6 BST1 exhibited a base-exchange activity against NR and NAR. a Scheme showing a base-exchange reaction between non-labeled NR and d4-NA to generate d4-NAR and non-labeled NAM. b, c NR and d4-NA were incubated with mouse intestinal tissue lysate or buffer for 30 min at room temperature. Then, the whole mixture was subjected to LC/MS analysis to detect d4-NAR as a product of base-exchange reaction. Representative MRM chromatograms (b) and calculated MS counts (cof d4-NAR after the incubation with lysates were shown (n = 3 independent experiments). d Only NR was incubated with mouse intestinal tissue lysate for 30 min at room temperature. Then, the whole mixture was subjected to LC/MS analysis to detect non-labeled NAR as a product of direct deamidation. Representative MRM chromatograms of non-labeled after the incubation with lysates were shown. e Caco2 cells were cultured with non-labeled NR and d4-NA for 4 h. Then, metabolites were extracted from cells and subjected to LC/MS analysis for the detection of d4-NAR (n = 3 independent experiments). f NR and d4-NA were incubated with intestinal tissue lysates from WT, CD38 KO, or BST1 KO mice for 30 min at room temperature. Then, the mixture was subjected to LC/MS analysis for d4-NAR detection (n = 4 independent experiments). g Non-labeled NR and d4-NA were incubated with recombinant CD38 or BST1 protein for 30 min at room temperature. Then, the mixture was subjected to LC/MS analysis for the detection of d4-NAR (n = 3 independent experiments). h Non-labeled NAR and d4-NAM were incubated with recombinant CD38 or BST1 protein for 30 min at room temperature. Then, the mixture was subjected to LC/MS analysis for the detection of d4-NR (n = 3 independent experiments). i Enzyme activity of BST1 for NR and NAR to catalyze base-exchange reaction. Recombinant BST1 protein was incubated with various concentrations of NR and 1 mM NA or NAR and 1 mM NAM and the produced NAR or NR, respectively, was measured by LC/MS analysis. Michaelis–Menten curve fit was produced with GraphPad Prism software. Right panel shows Km and Vmax. (n = 3 independent experiments) c, e–h Data are shown as mean ± S.D. i Each data point is shown. b, d Three independent experiments were performed. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 7 NAD+ is generated through distinct pathways in the small intestine of NADS KO mice during NR oral administration. Wild type (WT) and NADS KO mice were gavaged with quadruple-labeled NR, then were killed after 3 h of the gavage. a Scheme showing formation of isotope-labeled NAD+ metabolites after the oral administration of quadruple-labeled NR in the small intestine. b Concentration of unlabeled (m + 0) and labeled (m + 1, m + 2, m + 3, m + 4, m + 5 and m + 6) NAD+ metabolome in the small intestine was measured by LC/MS 3 h after the gavage of quadruple-labeled NR (n = 6 mice per group). Black and red lines indicated statistical analysis for m + 1 and m + 4 labeled metabolites, respectively. Data are shown as mean ± S.D. Statistical significance was determined by One-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.
Fig. 7 NAD+ is generated through distinct pathways in the small intestine of NADS KO mice during NR oral administration. Wild type (WT) and NADS KO mice were gavaged with quadruple-labeled NR, then were killed after 3 h of the gavage. a Scheme showing formation of isotope-labeled NAD+ metabolites after the oral administration of quadruple-labeled NR in the small intestine. b Concentration of unlabeled (m + 0) and labeled (m + 1, m + 2, m + 3, m + 4, m + 5 and m + 6) NAD+ metabolome in the small intestine was measured by LC/MS 3 h after the gavage of quadruple-labeled NR (n = 6 mice per group). Black and red lines indicated statistical analysis for m + 1 and m + 4 labeled metabolites, respectively. Data are shown as mean ± S.D. Statistical significance was determined by One-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 8 NAD+ is generated via base-exchange reaction in the small intestine of NADS KO mice. Wild-type (WT) and NADS KO mice were gavaged with d4-NA, then were killed after 3 h of the gavage. a Scheme showing formation of labeled and non-labeled NAD+ metabolome from d4-NA. b Concentration of unlabeled (m + 0) and labeled (m + 1, m + 2, m + 3, and m + 4) NAD+ metabolome in the small intestine was measured by LC/MS 3 h after the gavage of d4-NA (n = 6 mice per saline or d4-NA-treated WT mice group, n = 4 mice per saline-treated NADS KO mice group, n = 7 mice per d4-NA-treated NADS KO mice group). Data are shown as mean ± S.D. Black and blue lines indicated statistical analysis for non-labeled and labeled metabolites, respectively. ns not significant. Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.
Fig. 8 NAD+ is generated via base-exchange reaction in the small intestine of NADS KO mice. Wild-type (WT) and NADS KO mice were gavaged with d4-NA, then were killed after 3 h of the gavage. a Scheme showing formation of labeled and non-labeled NAD+ metabolome from d4-NA. b Concentration of unlabeled (m + 0) and labeled (m + 1, m + 2, m + 3, and m + 4) NAD+ metabolome in the small intestine was measured by LC/MS 3 h after the gavage of d4-NA (n = 6 mice per saline or d4-NA-treated WT mice group, n = 4 mice per saline-treated NADS KO mice group, n = 7 mice per d4-NA-treated NADS KO mice group). Data are shown as mean ± S.D. Black and blue lines indicated statistical analysis for non-labeled and labeled metabolites, respectively. ns not significant. Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 9 NAD+ is generated through Preiss–Handler pathway during chronic NR administration. Wild-type (WT) mice and Naprt KO mice were gavaged with 100 mg/kg NR or saline for 2 weeks or supplied NR in drinking water for 4 weeks. Mice were killed on last day after 3 h of gavage or in the morning for drinking water group. Concentrations of NAD+ metabolome in the liver were measured by LC/MS for gavage group (a) (n = 6 mice per group) and drinking water group (b) (n = 6 mice per group). Data are shown as mean ± S.D. ns not significant. Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.
Fig. 9 NAD+ is generated through Preiss–Handler pathway during chronic NR administration. Wild-type (WT) mice and Naprt KO mice were gavaged with 100 mg/kg NR or saline for 2 weeks or supplied NR in drinking water for 4 weeks. Mice were killed on last day after 3 h of gavage or in the morning for drinking water group. Concentrations of NAD+ metabolome in the liver were measured by LC/MS for gavage group (a) (n = 6 mice per group) and drinking water group (b) (n = 6 mice per group). Data are shown as mean ± S.D. ns not significant. Statistical significance was determined by one-way ANOVA followed by Tukey’s post-hoc tests. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 10 Schematic diagram showing metabolic fates of orally administered NR in vivo. Part of orally administered NR is directly absorbed from the small intestine. Orally administered NR is also degraded to NAM by BST1 in the small intestine. NAM derived from NR is further metabolized to NA by gut microbiota in the large intestine. Then, NA absorbed from the large intestine is used for the generation of NAD+ in the liver via the Preiss–Handler pathway. However, the base-exchange reaction for NR and NAR may function as a backup route when Preiss–Handler pathway is impaired.
Fig. 10 Schematic diagram showing metabolic fates of orally administered NR in vivo. Part of orally administered NR is directly absorbed from the small intestine. Orally administered NR is also degraded to NAM by BST1 in the small intestine. NAM derived from NR is further metabolized to NA by gut microbiota in the large intestine. Then, NA absorbed from the large intestine is used for the generation of NAD+ in the liver via the Preiss–Handler pathway. However, the base-exchange reaction for NR and NAR may function as a backup route when Preiss–Handler pathway is impaired.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Cited by

See all 76

Metadata

Authors
Yaku, K., Palikhe, S., Izumi, H., Yoshida, T., Hikosaka, K., Hayat, F., Karim, M., Iqbal, T., Nitta, Y., Sato, A., Migaud, M. E., Ishihara, K., Mori, H., & Nakagawa, T.
Affiliations
  • University of Toyama (JP)
  • USA Mitchell Cancer Institute (US)
  • Tokyo University of Technology (JP)
  • Kawasaki Medical School (JP)
Corresponding author
Nakagawa, Takashi
Venue
Nature Communications
Published
2021-11-19
Volume
12
Issue
1
Pages
6767-6767
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3213809584
Cited by
76
References
73
Citations by year
2026: 9 · 2025: 17 · 2024: 14 · 2023: 26 · 2022: 9 · 2021: 1
FWCI
6.92
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • MEXT | Japan Society for the Promotion of Science (18K17921, 21K11593, 20K20655)
  • LOTTE Foundation
  • Honjo International Scholarship Foundation
  • Otsuka Toshimi Scholarship Foundation
  • Rotary Yoneyama Memorial Foundation
  • Takeda Science Foundation
  • Takeda Medical Research Foundation
  • Kobayashi Foundation, Tamura Science & Technology Foundation, Takahashi Industrial and Economic Research Foundation, Moonshot R&D (Grant Number JPMJMS2021),
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
  • Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
Keywords
nicotinamide riboside, BST1, NAD+ metabolism, nicotinamide, nicotinic acid, Preiss-Handler pathway, gut microbiota, glycoside hydrolases, aging, oral supplementation
MeSH terms
Gastrointestinal Microbiome, A549 Cells, Administration, Oral, Aging, Animals, Glycoside Hydrolases, Humans, Intestinal Mucosa, Intestine, Small, Niacin, Niacinamide, Pentosyltransferases, Pyridinium Compounds, Antigens, CD, Mice, Knockout, Dietary Supplements, ADP-ribosyl Cyclase, Mice, GPI-Linked Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities. https://app.cochat.ai/papers/10.1038/s41467-021-27080-3
The paper
Yaku, K., Palikhe, S., Izumi, H., Yoshida, T., Hikosaka, K., Hayat, F., Karim, M., Iqbal, T., Nitta, Y., Sato, A., Migaud, M. E., Ishihara, K., Mori, H., & Nakagawa, T. (2021). BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities. Nature Communications. https://doi.org/10.1038/s41467-021-27080-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.